| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |